Treated (n = 32) | Controls (n = 26) | p | ||
---|---|---|---|---|
Gender (male %) | 63% | 50% | 0.3 | |
Age (yr) | 63 ± 15 | 73 ± 12 | 0.02 | |
Origin of sepsis | ||||
Abdominal | 56% | 42% | ||
Bone | 0% | 4% | ||
Respiratory | 34% | 27% | ||
Skin/soft tissue | 10% | 23% | ||
Urinary tract | 0% | 4% | ||
SAPS II | 56 ± 13 | 59 ± 11 | 0.4 | |
APACHE II | 25 ± 6 | 24 ± 7 | 0.6 | |
SOFA score at inclusion | 11 ± 3 | 11 ± 2 | 0.4 | |
Value at inclusion | Mean arterial pressure (mmHg) | 77 ± 9 | 75 ± 11 | 0.6 |
Norepinephrine dose (mcg/kg/min) | 0.8 ± 1.0 | 0.4 ± 0.33 | 0.04 | |
Heart rate (bpm) | 94 ± 20 | 96 ± 22 | 0.7 | |
Lactate (mmol/L) | 3.5 ± 2.0 | 4.0 ± 3.5 | 0.6 | |
pH | 7.30 ± 0.11 | 7.31 ± 0.12 | 0.8 | |
Base deficit (mmol/L) | −9.0 ± 4.3 | −7.5 ± 7.2 | 0.4 | |
ScvO2 (%) | 70 ± 10 | 71 ± 13 | 0.8 | |
SpO2 (%) | 96 ± 4 | 98 ± 3 | 0.2 | |
PaO2/FiO2 | 181 ± 102 | 255 ± 164 | 0.3 | |
Hb (g/dL) | 11.2 ± 2.0 | 10.9 ± 2.2 | 0.6 | |
StO2 (%) | 80 ± 8 | 78 ± 12 | 0.5 | |
Deoxygenation slope (%/min) | −16.2 ± 18 | −17.4 ± 14.4 | 0.4 | |
Reoxygenation slope (%/s) | 3.2 ± 2.6 | 2.3 ± 1.8 | 0.1 | |
Mortality (n, %) | 6 (19) | 10 (38) | 0.09 | |
Length of ICU stay (days) | 26 ± 21 | 19 ± 17 | 0.2 |